Printer Friendly

Browse Nervous system diseases topic

 

Articles

1-300 out of 600 article(s) nextnext page
Title Author Type Date Words
Kuwaiti neurologist partakes in int'l conf. in Japan. Sep 21, 2017 183
XW Labs secures over $17M Series B financing led by Elements Capital and WI Harper. Sep 20, 2017 519
Disarm Therapeutics Unveils Breakthrough Approach to Treat Patients with Neurological Diseases by Preventing Axonal Degeneration. Sep 19, 2017 1078
United States : Schumer, Gillibrand Announce More Than $2.7 Million In Fed Funds For Winifred Masterson Burke Medical Research Institute. Sep 16, 2017 269
United States : Hunters Reminded of Importation Restrictions to Help Keep Tennessee CWD Free. Sep 16, 2017 309
UCB's new antiepileptic drug BRIVIACT approved by US FDA as monotherapy treatment for partial-onset seizures in adults. Sep 15, 2017 310
UCB's new antiepileptic drug BRIVIACT approved by US FDA as monotherapy treatment for partial-onset seizures in adults. Sep 15, 2017 306
BioAxone BioSciences Awarded NINDS SBIR Funding for the Development of Self-Delivering RNAi (sd-rxRNA) for the Treatment of Spinal Cord Injury. Sep 15, 2017 1181
International Collaborative Study Reveals The Neuroprotective Properties of Phytocannabinoid [eth]o9-THCA. Sep 12, 2017 956
Global Central Nervous System Partnering 2010-2017: Deal trends, players and financials. Sep 11, 2017 1159
Healthy Hints. Sep 11, 2017 307
Advicenne Announces Positive Pivotal Phase III Clinical Data for ADV7103 in Adults and Children Suffering from distal Renal Tubular Acidosis (dRTA). Sep 11, 2017 958
Advicenne Announces Positive Pivotal Phase III Clinical Data for ADV7103 in Adults and Children Suffering from distal Renal Tubular Acidosis (dRTA). Sep 11, 2017 962
Biohaven To Provide Development Program Update At The Morgan Stanley 15th Annual Global Healthcare Conference. Conference news Sep 11, 2017 707
Global Neuroprotection Drugs, Markets and Companies Forecasts 2016-2021 & 2026. Sep 11, 2017 548
Global Neuroprotection Drugs, Markets and Companies Forecasts 2016-2021 & 2026. Sep 11, 2017 582
Global Central Nervous System Partnering Report 2010-2017: Latest Deal Trends, Players and Financials. Sep 8, 2017 768
Global Central Nervous System Partnering Report 2010-2017: Latest Deal Trends, Players and Financials. Sep 8, 2017 802
Global physiotherapy equipment market size reached USD 15.6 billion in 2016 and is predicted to garner USD 25.0 billion by the end of 2024. Sep 6, 2017 528
United Kingdom : Stabilizing TREM2 a potential strategy to combat Alzheimers disease. Sep 2, 2017 512
Does dementia mean giving up the car keys? when a person loses driving privileges depends on disease progression. Having a strategy in place can make the change easier. Sep 1, 2017 639
Records Derived From The Health Innovation Plan Code 100. Sep 1, 2017 205
Designer genes. Jacobsen, Rowan Sep 1, 2017 3302
The Next Step in Treating Gait and Walking Functions in Older Adults. Aug 31, 2017 929
New Antibodies Target Structures Shared by Proteins Thought to Worsen Several Neurological Diseases. Aug 29, 2017 958
Dancing can fight ageing of the brain. Aug 26, 2017 122
Age- and gender-related differences in drug utilization patterns among patients in neurology ward of a tertiary care hospital. Bose, Debdipta; M., Sushma; Agadi, Jagadish B. Report Aug 24, 2017 6148
Evaluation of anticonvulsant activity of ethanolic extract of leaves of Ocimum sanctum (tulsi) in albino rats. Manu, Gangadhar; Padmanabha, Shivaraju Thiruganahalli; Chandrakantha, Thippeswamy; Ravishankar, Manc Report Aug 24, 2017 2521
Nortis wins USD688,000 NIH grant from the National Institute of Neurological Disorders and Stroke. Aug 21, 2017 233
Nortis wins USD688,000 NIH grant from the National Institute of Neurological Disorders and Stroke. Aug 21, 2017 229
Huntington's Disease Society of America Announces Team Hope Walk in Las Vegas, NV. Aug 19, 2017 482
Nortis Awarded $688K NIH Phase II SBIR Fast Track Grant to Develop Living Model of Human Blood-Brain Barrier. Aug 18, 2017 492
United States : Scientists give star treatment to lesser-known cells crucial for brain development. Aug 17, 2017 838
India : Suven Life secures Process Patents in Europe, Japan and New Zealand. Aug 17, 2017 166
United States : Pomerantz LLP Appointed Co-Lead Counsel in Neurotrope, Inc. Securities Litigation. Aug 17, 2017 297
Papapetropoulos Joins Cavion as Executive Vice President, R and D, and Chief Medical Officer. Aug 16, 2017 229
Global Radiopharmaceuticals Market to Grow at a CAGR of 9% by 2021: Rising Burden of the Neurological Disorders. Aug 16, 2017 540
Global Radiopharmaceuticals Market to Grow at a CAGR of 9% by 2021: Rising Burden of the Neurological Disorders. Aug 16, 2017 574
Global Neurointerventional Market 2017-2023 by Product Type, End-Users, and Regions. Aug 14, 2017 836
Global Neurointerventional Market 2017-2023 by Product Type, End-Users, and Regions. Aug 14, 2017 870
WHO, mhGAP to bridge treatment gap in mental, neurological disorders. Aug 12, 2017 436
WHO mhGAP to bridge treatment gap in mental, neurological disorders. Aug 12, 2017 468
Mitsubishi Tanabe unveils intravenous RADICAVA therapy in the US for treating amyotrophic lateral sclerosis. Aug 9, 2017 240
Mitsubishi Tanabe unveils intravenous RADICAVA therapy in the US for treating amyotrophic lateral sclerosis. Aug 9, 2017 236
Newly Formed Brain Research Foundation Young Leadership Board Announces the 2nd Annual "Let's Put Our Heads Together" Fundraiser. Aug 9, 2017 671
CNS Therapeutics Market Worth $128.9 Billion by 2025 / CAGR: 5.9%: Grand View Research, Inc. Aug 8, 2017 930
CNS Therapeutics Market Worth $128.9 Billion by 2025 / CAGR: 5.9%: Grand View Research, Inc. Aug 8, 2017 937
Mercaptor Discoveries Inc. Appoints Three New Members, Including Former NFL Linebacker, to Board of Directors. Aug 8, 2017 555
Polaryx Therapeutics Receives Orphan Drug Designation From the U.S. FDA for PLX-200 for Rare Pediatric Disease. Aug 7, 2017 746
Alkahest Appoints Helen Jenkins as Chief Operating Officer. Aug 7, 2017 532
NIH Awards BioAxone BioSciences USD 1.5m SBIR Grant. Aug 4, 2017 248
Global Tauopathies Market Analysis 2017 - Key Trends, Innovative Products, Market Segments, and Companies. Aug 4, 2017 543
Neuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017. Aug 3, 2017 670
QB3953 enters into new partnership with Toray, Japan. Aug 2, 2017 244
QB3953 enters into new partnership with Toray, Japan. Aug 2, 2017 240
Aptinyx Initiates Phase 2 Clinical Studies Evaluating NYX-2925 in Two Chronic Pain Conditions. Aug 1, 2017 1038
ALS Association Launches Home Health Initiative with Support from Major League Baseball. Aug 1, 2017 681
Japanese chemical firm Toray partners with QB3@953 to pursue breakthroughs in treatment of neurological diseases. Aug 1, 2017 675
The Wild, Wild West Sparkled With Keep Memory Alive At Annual Summer Social And Rodeo At Shakespeare Ranch, July 28 And 29. Aug 1, 2017 828
Amyotrophic lateral sclerosis (Lou Gehrig's disease) ... Etingin, Orli R. Aug 1, 2017 358
New ALS drug therapy. Aug 1, 2017 260
EID podcast: deadly parasite in raccoons. Brief article Aug 1, 2017 163
California serogroup virus infection associated with encephalitis and cognitive decline, Canada, 2015. Webster, Duncan; Dimitrova, Kristina; Holloway, Kimberly; Makowski, Kai; Safronetz, David; Drebot, M Aug 1, 2017 1398
Zika virus screening among Spanish team members after 2016 Rio de Janeiro, Brazil, Olympic Games. Rodriguez-Valero, Natalia; Borobia, Alberto M.; Lago, Mar; Sanchez-Seco, Maria Paz; de Ory, Fernando Aug 1, 2017 1502
Pinpointing the cause of Tourette syndrome. Aug 1, 2017 209
H. Lundbeck reports approval by US FDA of Abilify Maintena for extended-release injectable suspension for maintenance monotherapy treatment of bipolar I disorder (BP I) in adults. Jul 31, 2017 252
H. Lundbeck reports approval by US FDA of Abilify Maintena for extended-release injectable suspension for maintenance monotherapy treatment of bipolar I disorder (BP I) in adults. Jul 31, 2017 248
VMS BioMarketing Joins the Fight Against ALS by Supporting Patients Through Nurse-Led Education. Jul 27, 2017 540
BrainStorm Announces Agreement with University of California Irvine Medical Center to Participate in Phase 3 Trial of NurOwn in ALS. Jul 25, 2017 900
United States : IBM and University of Alberta Publish New Data on Machine Learning Algorithms to Help Predict Schizophrenia. Jul 22, 2017 337
Brainstorm Awarded $16 Million Non-Dilutive Grant from CIRM in Support of Phase 3 Clinical Trial of NurOwn in ALS. Jul 21, 2017 977
Today's Research Report Coverage on Biotech Stocks -- ACADIA Pharma, Aduro BioTech, Agios Pharma, and AveXis. Jul 20, 2017 1708
Predictive evaluation of mortality and morbidity in cases of intracerebral haemorrhage by CT scan. Kumar, Naresh; Dinkar, Jyoti Kumar Report Jul 20, 2017 1986
United States : Ionis Earns $10 Million Milestone Payment from Biogen for Advancing a New Program in its Neurology Collaboration. Jul 18, 2017 167
United States : Space station project seeks to crystalize the means to counteract nerve poisons. Jul 18, 2017 766
BrainStorm Announces Agreements with Mass. General Hospital and California Pacific Medical Center to Participate in Phase 3 Trial of NurOwn in ALS. Jul 18, 2017 1014
New Neurology Program Earns Ionis USD 10m Milestone Payment from Biogen. Jul 18, 2017 130
2017 Weston Brain Institute International Outstanding Achievement Award Winner. Jul 17, 2017 742
Ionis Earns $10 Million Milestone Payment from Biogen for Advancing a New Program in its Neurology Collaboration. Jul 17, 2017 892
New Imaging Technique Fast Enough to Watch Molecular Dynamics Involved in Neurodegenerative Diseases, Optica Reports. Jul 17, 2017 768
Enterin Inc. Raises $12.7 Million in Series A Financing. Jul 15, 2017 765
USPTO Issues Notice of Allowance to Biohaven on Patent Application for Glutamate Modulating Prodrugs. Jul 14, 2017 253
Neuraltus Enrolls 138 Patients in Study of NP001 in ALS with Systemic Inflammation. Clinical report Jul 13, 2017 364
Accera signs strategic partnership and exclusive South Korea licensing agreement with DuChemBio. Jul 12, 2017 178
Accera signs strategic partnership and exclusive South Korea licensing agreement with DuChemBio. Jul 12, 2017 182
E-Scape Bio Series A Extension Brings Total Round to $63 Million to Fund Neurodegenerative Disease Pipeline. Jul 12, 2017 638
Neuraltus Announces Completion of Enrollment in Confirmatory Phase 2 Study of NP001 in ALS Patients with Systemic Inflammation. Clinical report Jul 12, 2017 606
CSL Behring Awards Researchers to Advance Immunoglobulin Therapy in Treating Neurological Disorders. Jul 11, 2017 752
Nuredis Appoints Julie Anne Smith as Chief Executive Officer to Lead Neurodegenerative Disease Company. Jul 11, 2017 556
Select Medical And SSM Health Open New Acute Rehabilitation Hospital In Lake Saint Louis. Jul 11, 2017 686
Accera Enters into a Strategic Partnership and Exclusive Licensing Agreement with DuChemBio for Accera's Technology in Korea. Jul 11, 2017 895
New Data Presented at Peripheral Nerve Society Meeting Further Support Potential Benefit of Inotersen. Jul 10, 2017 1703
Advicenne Receives Orphan Drug Designation From the EU for ADV7103 for the Treatment of Distal Renal Tubulopathy. Jul 5, 2017 782
Advicenne Receives Orphan Drug Designation From the EU for ADV7103 for the Treatment of Distal Renal Tubulopathy. Jul 5, 2017 786
World Neuroprotection Report 2017: Drugs, Markets and Companies Projections 2016-2026. Report Jul 5, 2017 547
Global Drug Delivery in Central Nervous System Diseases 2016-2026 - Focus on Technologies, Markets and Companies. Jul 5, 2017 627
World Neuroprotection Report 2017: Drugs, Markets and Companies Projections 2016-2026. Report Jul 5, 2017 587
Global Drug Delivery in Central Nervous System Diseases 2016-2026 - Focus on Technologies, Markets and Companies. Jul 5, 2017 667
Emaar Foundation Hosts Charity Art Auction to Raise Awareness of ALS; Proceeds Donated to Al Jalila Foundation for Research and Medical Support for ALS Patients in the UAE. Jul 3, 2017 748
Worldwide Clinical Trials Selected by BrainStorm as CRO for Phase 3 NurOwn Trial in ALS. Jul 3, 2017 845
Mixed phenotypic acute leukemia with leukemia cutis and neuroleukemiosis. Poikayil, Rona Joseph; Narayanan, Geetha; Sugathan, Harish; Soman, Lali V. Clinical report Jul 1, 2017 981
Usefulness of positron emission tomography to detect cerebral amyloid as a means to diagnose neurodegenerative disease. Page, Jessica; Oza, Umesh; Layton, Kennith; Padilla, Claudia Clinical report Jul 1, 2017 1319
Reversing MS damage. Jul 1, 2017 339
New ALS drug. Jul 1, 2017 223
New technology is major game-changer. Tseng, Henry Jul 1, 2017 198
Health surveillance and response on a regional scale: a preliminary study of the Zika virus fever case. Bueno, Flavia Thedim Costa Jul 1, 2017 6493
Glutamate's exciting roles in body, brain, and mind: a fertile future pharmacotherapy target. Nasrallah, Henry A. Editorial Jul 1, 2017 1504
The saliva exposome for monitoring of individuals' health trajectories. Bessonneau, Vincent; Pawliszyn, Janusz; Rappaport, Stephen M. Jul 1, 2017 8927
Mum earns degree after illness fight. Jun 30, 2017 110
Metformin attenuate PTZ-induced apoptotic neurodegeneration in human cortical neuronal cells. Jun 30, 2017 2645
Arix Bioscience acquires share in Mitoconix Bio. Jun 29, 2017 209
Arix Bioscience acquires share in Mitoconix Bio. Jun 29, 2017 205
Alcyone Lifesciences Enters into a Feasibility Study Agreement with Pfizer to Evaluate Alcyone's proprietary Pulsar(TM) Advanced Intrathecal Precision Delivery Platform Technology for use in Gene Therapy Targeting Central Nervous System Disorders. Jun 29, 2017 681
Hinchey Family Announces That Former Congressman Maurice D. Hinchey Suffers From Frontotemporal Degeneration (FTD). Jun 28, 2017 484
Mitoconix Bio Raises $20 Million in Series A Funding to Develop Neurodegenerative Disease Therapies. Jun 27, 2017 774
Cerveau Technologies, NYU Langone Medical Center to Collaborate. Jun 27, 2017 196
Global unity and alliance in Brain Mapping and Therapeutics will be achieved in Germany during the G20 Summit at 4th Annual G20 BRAIN Initiative/Neuroscience-20 symposium. Jun 27, 2017 855
Meeting the care challenge; Dr Liz Sampson, of University College London, explains why high-quality end-of-life care is so vital. Jun 26, 2017 697
Biohaven Broadens Senior Leadership Team With Veteran Pharma Executives. Jun 22, 2017 1144
Enrollment in Phase 1/2a Study of IONIS-HTT Rx in Patients with Huntington's Disease Completed and Open-Label Extension Study to Open in 2H 2017. Jun 22, 2017 1298
A human brain microphysiological system derived from induced pluripotent stem cells to study neurological diseases and toxicity. Pamies, David; Barreras, Paula; Block, Katharina; Makri, Georgia; Kumar, Annpama; Wiersma, Daphne; S Report Jun 22, 2017 8425
Advicenne to Present Preliminary Phase III Clinical Data on ADV7103 at the Upcoming European Society of Paediatric Nephrology's Annual Meeting. Jun 21, 2017 628
Advicenne to Present Preliminary Phase III Clinical Data on ADV7103 at the Upcoming European Society of Paediatric Nephrology's Annual Meeting. Jun 21, 2017 632
Rashid Hospital Doctors congratulated for rare diagnosis. Jun 18, 2017 368
BrainStorm to Provide Corporate Update at the BIO International Convention. Jun 14, 2017 341
Aptinyx to Present Data for NYX-2925 at the 6th International Congress on Neuropathic Pain. Clinical report Jun 14, 2017 381
Numerate, Takeda Team to Generate Novel Clinical Candidates Using AI-Driven Drug Discovery. Jun 14, 2017 246
BrainStorm Awarded $2.1 Million Non-Dilutive Grant for 2017 by the Israel Innovation Authority. Jun 13, 2017 928
Global Neuromodulation Devices Market to Reach $17.6 Billion by 2025 - Rising Occurrence of Neurological Disorders - Research and Markets. Industry overview Jun 13, 2017 497
Global Neuromodulation Devices Market to Reach $17.6 Billion by 2025 - Rising Occurrence of Neurological Disorders - Research and Markets. Industry overview Jun 13, 2017 537
Wilson Therapeutics announces US Orphan Drug Designation receipt for WTX101 to treat ALS. Jun 12, 2017 284
Wilson Therapeutics announces US Orphan Drug Designation receipt for WTX101 to treat ALS. Jun 12, 2017 280
Dr. Joan Fallon, CEO Of Curemark, Named EY Entrepreneur Of The Year 2017 Award Finalist In New York. Jun 6, 2017 973
2017 Innovation Authority Budget Approved for Kadimastem: NIS 12 M for ALS Project. Jun 5, 2017 793
Aequus Pharmaceuticals to Collaborate with CDRD on Cannabinoid-based Therapeutics Research. Jun 5, 2017 367
Canada : Aequus Pharmaceuticals and CDRD Announce Research Collaboration to Improve Cannabinoid-Based Therapeutics. Jun 2, 2017 498
The experiences of medical marijuana patients: A scoping review of the qualitative literature. Ryan, Jennie; Sharts-Hopko, Nancy Report Jun 1, 2017 3823
Shorts. Klotter, Jule Jun 1, 2017 2225
Management of electronic waste disposal in India. Sivakumaran, R.P.; Anandkumar, K.M.; Shanmugasundaram, G. Jun 1, 2017 3328
Severe neurologic disorders in 2 fetuses with Zika virus infection, Colombia. Acosta-Reyes, Jorge; Navarro, Edgar; Herrera, Maria Jose; Goenaga, Eloina; Ospina, Martha L.; Parra, Jun 1, 2017 2172
ProMIS Neurosciences Identifies Novel Therapeutic Epitope Target for ALS and Dementia. May 31, 2017 712
New protocol for deriving microglia from human stem cells. May 29, 2017 297
New protocol for deriving microglia from human stem cells. May 29, 2017 330
Israel : New Drug Therapy Developed by Ben-Gurion University Researchers Could Improve Brain Function and Life Expectancy in ALS Patients. May 24, 2017 385
Electroencephalography (EEG) Systems/Devices Market Analysis By Product, By Type, By End Use And Segment Forecasts 2014 - 2025 - Research and Markets. May 22, 2017 828
Electroencephalography (EEG) Systems/Devices Market Analysis By Product, By Type, By End Use And Segment Forecasts 2014 - 2025 - Research and Markets. May 22, 2017 788
BrainStorm to Present at Cell & Gene Exchange Conference in Washington DC. Conference news May 22, 2017 1004
Researchers discover reason for "leaky" brain blood vessels in Huntington's. Thompson, Leslie M. May 22, 2017 531
New protocol for deriving microglia from human stem cells. Douvaras, Panagiotis May 22, 2017 296
RM Global Partners Completes $30 Million First Closing of New Israel-Based Biopharma Fund. May 18, 2017 789
Aptinyx to Present NYX-2925 Research at American Pain Society Annual Scientific Meeting. May 17, 2017 477
Abide Therapeutics to Present at EUFEMED Annual Meeting on ABX-1431 Clinical Program. May 17, 2017 857
Blackfynn advances neuroscience data integration and analytics platform with additional funding and strategic collaborations. May 17, 2017 481
BrainStorm Initiated Technology Transfer to City of Hope for U.S. Production of NurOwn for Phase 3 ALS Study. Clinical report May 16, 2017 957
Global Central Nervous System Partnering 2010 - 2017: Deal trends, players and financials. May 16, 2017 1313
Biohaven's Trigriluzole Receives Fast Track Designation From U.S. FDA. May 15, 2017 1046
Human Longevity, Inc. Launches Pilot Program, Health Nucleus X. May 11, 2017 641
Dr. Harvey's Groundbreaking New Dog Food "Paradigm" Is Ideal For Low Carb, Low Glycemic Or Ketogenic Diet For Dogs. May 10, 2017 604
Biscayne Readies Phase 1b Trial for Novel Antiepileptic Agent BIS-001 and Receives FDA Orphan Drug Designation for Dravet Syndrome. May 9, 2017 1029
Global Cerebrospinal Fluid (CSF) Management Devices Market to Grow at a CAGR of 3.9% by 2021: Driven by an Increase in Prevalence of Neurological Disorders - Research and Markets. May 9, 2017 467
Global Cerebrospinal Fluid (CSF) Management Devices Market to Grow at a CAGR of 3.9% by 2021: Driven by an Increase in Prevalence of Neurological Disorders - Research and Markets. May 9, 2017 507
Tau Immunotherapy Shows Great Potential in Pre-Clinical Studies. Clinical report May 8, 2017 786
Global Neuromodulation Market (By Application, Technology, Region and Company) and Forecast to 2021 - Research and Markets. May 5, 2017 654
Global Neuromodulation Market (By Application, Technology, Region and Company) and Forecast to 2021 - Research and Markets. May 5, 2017 694
MT Pharma America Announces FDA Approval of RADICAVA(TM) (Edaravone), the First New Treatment Option for ALS in More Than 20 Years. May 5, 2017 1870
Neuro-Bio Ltd Appoints Dr. Robert Haigh as Chief Operating Officer. May 4, 2017 481
Breakthrough Regenerative Therapeutics Company Establishes Scientific Advisory Board. May 4, 2017 1590
Edison Issues Outlook on Oryzon Genomics (ORY). May 2, 2017 571
Stealth BioTherapeutics Initiates Phase 1/2 Trial of SBT-20 in Patients With Early Stage Huntington's Disease. May 2, 2017 960
Mercaptor Tackles Neurodegenerative Diseases. May 2, 2017 445
Diagnosis, monitoring and treatment of tuberous sclerosis complex: a South African consensus response to International guidelines. de Vries, P.J.; Leclezio, L.; Wilmshurst, J.M.; Fieggen, G.; Gottlich, E.; Jacklin, L.; Naiker, I.P. Report May 1, 2017 8850
BrainStorm to Present at Two Scientific Conferences in May. Conference news May 1, 2017 1401
Takeda Pharmaceutical to collaborate with Harrington Discovery Institute. May 1, 2017 188
Takeda Pharmaceutical to collaborate with Harrington Discovery Institute. May 1, 2017 184
Urine-powered autonomous sensor could catch UTIs early. May 1, 2017 1652
Food to feed the brain: Nutrients influence cognition by acting on molecular systems or cellular processes that are vital for increasing and maintaining proper function. Ghosh, Dilip May 1, 2017 1018
Systemic and neurotoxic effects of epidural meloxicam in rabbits/Efeitos sistemicos e neurotoxicos do meloxicam por via epidural em coelhos. da Costa Felipe, Gracineide; Vieira Henrique, Fernanda; Otaviano do Rego, Renato; Pereira Alves, Ala Ensayo May 1, 2017 3805
Absence of Septum Pellucidum and Gray Matter heteropia in a patient with schizoaffective disorder and intractable epileptic seizures: a case report. Farooq, Mobeen; Melvin, Kelly Clinical report May 1, 2017 2210
Providing Services For Sanatorium Treatment Of Children With Disabilities And Accompanying Persons, Having Residence In The Moscow Region, In The Establishment, Located In The Territory Of The Republic Of Crimea (black Sea Coast) And Specializes In The Tr. Apr 30, 2017 157
Providing Services For Sanatorium Treatment Of Children With Disabilities And Accompanying Persons, Having Residence In The Moscow Region, In The Establishment, Located On The Territory Of Krasnodar Region (black Sea Coast) And Specializes In The Treatmen. Apr 30, 2017 155
Japan,United States : Takeda and Harrington Discovery Institute at University Hospitals Announce a Collaboration to Advance the Development of Rare Disease Therapeutics. Apr 29, 2017 386
United States : Antidepressant may enhance drug delivery to the brain. Apr 29, 2017 493
United States : FDA Clears Flex Pharma's FLX-787 to Commence US Phase 2 Trial in ALS Under IND. Clinical report Apr 29, 2017 506
ALS Awareness Month--May 2017. Apr 28, 2017 290
Electroencephalography (EEG) Systems - Global Market Outlook (2016-2022). Apr 27, 2017 642
United States : Flex Pharma Presents Human Efficacy Data on FLX-787 at the American Academy of Neurology Annual Meeting. Apr 25, 2017 435
Aquinnah Pharmaceuticals Receives $10 Million Investment from Pfizer and AbbVie to Research Breakthrough Approach to Neurodegenerative Disease. Apr 25, 2017 476
Bionik Laboratories Reaches Milestone with Shipment of 250th Interactive Robotic Therapy System for Patient Rehabilitation. Apr 25, 2017 1023
Aquinnah Pharmaceuticals Receives $10 Million Investment from Pfizer and AbbVie to Research Breakthrough Approach to Neurodegenerative Disease. Apr 25, 2017 515
Sangamo Therapeutics Announces Presentations at 2017 Annual meeting of the American Society of Gene & Cell Therapy. Apr 24, 2017 1704
Researchers create 3D Brain tissue from stem cells in lab. Apr 24, 2017 624
Providing Services For Sanatorium Treatment Of Children With Disabilities And Accompanying Persons, Having Residence In The Moscow Region, In The Establishment, Located On The Territory Of Central Russia, Including The Moscow Region, And Specializes In Th. Apr 23, 2017 166
Belgium : New medicine for rare neurodegenerative disorder in children. Apr 22, 2017 720
Impax to Present Data on Rytary (Carbidopa and Levodopa) Extended-Release Capsules, Zomig (Zolmitriptan) Nasal Spray and Investigational Drug IPX203 at the 2017 American Academy of Neurology Annual Meeting. Apr 21, 2017 3433
Global Proteomics Technologies, Markets and Companies Report 2017-2026: 300+ Companies Identified in Proteomics - 224 Profiles with 456 Collaborations - Research and Markets. Report Apr 21, 2017 378
NLS Pharma Announces Presentations at 6th World Congress on ADHD. Apr 21, 2017 851
Global Proteomics Technologies, Markets and Companies Report 2017-2026: 300+ Companies Identified in Proteomics - 224 Profiles with 456 Collaborations - Research and Markets. Report Apr 21, 2017 418
Brainstorm Cell Therapeutics to Present at ARM's 5th Annual Cell & Gene Therapy Investor Day, April 27 in Boston. Apr 20, 2017 740
BrainStorm Announces Publication of NurOwn Autism Research Study. Apr 19, 2017 1064
NLS Pharma Announces Completion of Phase 2 Study for NLS-1, Its Lead ADHD Compound; New Investors, New Patents. Clinical report Apr 18, 2017 706
Relmada Granted FDA Fast Track Designation for d-Methadone for Adjunctive Treatment of Major Depressive Disorder. Apr 17, 2017 403
Global stem cell market CAGR to be 26 percent from 2017-2025. Apr 17, 2017 336
Global stem cell market cagr to be 26 percent from 2017-2025. Apr 17, 2017 334
Mission Therapeutics receives major research grant from MJFF. Apr 13, 2017 213
Mission Therapeutics receives major research grant from MJFF. Apr 13, 2017 209
United States : Menendez Visits Rutgers Cancer Institute of NJ to Illustrate the Impact of Trump Proposed Budget Cuts on Lifesaving Biomedical Research that Leads to New Cures, Treatments. Apr 13, 2017 686
HealthWell Foundation Launches New Fund to Assist Medicare Patients Living with Amyotrophic Lateral Sclerosis (ALS). Apr 12, 2017 768
Explaining the genetics behind rare neurological diseases: new drug screening platform for neurological therapeutic development. Apr 10, 2017 517
United States : Technique for Three-Parent Baby Revealed. Apr 4, 2017 742
Pseudobulbar affect: what nurses, stroke Survivors, and caregivers need to know. Schneider, Melissa A.; Schneider, Matthew D. Report Apr 1, 2017 2635
Aerobic fitness and neurocognitive function scores in young faroese adults and potential modification by prenatal methylmercury exposure. Oulhote, Youssef; Debes, Frodi; Vestergaard, Sonja; Weihe, Pal; Grandjean, Philippe Apr 1, 2017 7899
Prenatal exposure to glycol ethers and Neurocognitive abilities in 6-year-old children: The PELAGIE cohort study. Beranger, Remi; Garlantezec, Ronan; Maner-Idrissi, Gaid Le; Lacroix, Agnes; Rouget, Florence; Trowbr Apr 1, 2017 8557
Does the patient have a leukodystrophy? Importance of clinical description, semiotics and neuroimaging in the diagnostic suspicion of a metabolicorigin leukodystrophy/?Tiene el paciente una leucodistrofia? Importancia de la descripcion clinica, la semiologia y las neuroimagenes ante la sospecha diagnostica de leucodistrofia de origen metabolico.... Echeverri-Pena, Olga Yaneth; Mera, Paola; Cabarcas-Castro, Lissete; Ardila-Gomez, Yudi Andrea; Espin Apr 1, 2017 3315
Advicenne completes financing round for orphan renal treatments. Mar 20, 2017 269
Advicenne completes financing round for orphan renal treatments. Mar 20, 2017 265
Cerveau Technologies to License Investigational Imaging Agent to Sinotau Pharmaceutical. Mar 20, 2017 230
Acceleron to Launch Phase 2 Trial of ACE-083 in Charcot-Marie-Tooth Neuromuscular Disease. Mar 17, 2017 575
Kadimastem granted US patent for innovative cell technology. Mar 16, 2017 234
Kadimastem granted US patent for innovative cell technology. Mar 16, 2017 230
'Spongebob' creator Stephen Hillenburg diagnosed with ALS. Mar 15, 2017 367
Proclara Biosciences Subsidiary Awarded Biopharmaceuticals Australia Grant. Mar 13, 2017 414
A view to remember. Wannan, Olivia Mar 1, 2017 203
Natural methods to suppress destructive Cortisol. Goldschein, Susan Report Mar 1, 2017 2945
Assessment of airway defenses in the neurologically impaired patient. Miller, Sarah; Silverman, Erin; Hoffman-Ruddy, Bari Report Mar 1, 2017 3795
Brainstem reflexes in systemic lupus erythematosus patients without clinical neurological manifestations. Salcini, Celal; Bastan, Birgul; Sunter, Gulin; Kahraman Koytak, Pinar; Yilmaz, Orhan; Tanridag, Tuli Report Mar 1, 2017 3363
Assessment of Headache in Asthma Patients. Report Feb 28, 2017 3975
Induced hypothermia in neurocritical care: a review. Cook, Courtney J. Report Feb 1, 2017 5028
Valproic acid: special considerations and targeted monitoring. Collins-Yoder, Angela; Lowell, Jordan Report Feb 1, 2017 3252
Losing your sense of smell could be an early predictor of dementia: but there's a silver lining: this symptom could lead to earlier diagnosis and treatment. Feb 1, 2017 576
Global Neurodegenerative Drugs Market to Reach USD 45bn in 2022, Research and Markets Predicts. Jan 31, 2017 356
Biscayne Forms Neurotherapeutics Business, Closes USD 3m Venture Financing. Jan 30, 2017 361
Eye muscles found to resist ALS. Jan 30, 2017 633
H Lundbeck collaborates with IBM's Watson Health. Jan 27, 2017 223
H Lundbeck collaborates with IBM's Watson Health. Jan 27, 2017 219
Errol De Souza Named President, CEO at Neuropore Therapies. Jan 25, 2017 290
Enamine Expands Collaboration with Actelion Pharmaceuticals. Jan 25, 2017 386
Intracranial Pressure Monitoring Market to Reach USD 1.9bn by 2025, Grand View Research Predicts. Jan 20, 2017 357
'Mini-brains' could revolutionize neurological diseases research: researchers developing "mini-brains" in the lab hope to streamline the drug discovery process, reduce animal testing and unlock clues of complex neurological diseases. Scrudato, Lauren Jan 1, 2017 1337
Evaluation of retinal changes using optical coherence tomography in a pediatric case of susac syndrome. Kola, Mehmet; Erdol, Hidayet; Atasoy, Sevil Ertugrul; Turk, Adem Clinical report Jan 1, 2017 1690
Use of methanol and workers' risk of exposure at a biodiesel plant/Uso do metanol e risco de exposicao dos trabalhadores de uma usina de biodiesel. de Assis, Cristiane Silva; de Jesus, Leda Diva Freitas; de Miranda, Ary Carvalho; Moreira, Maria de Jan 1, 2017 7137
The physical and psychological impact of neurogenic claudication: the patients' perspectives. Ammendolia, Carlo; Schneider, Michael; Williams, Kelly; Zickmund, Susan; Hamm, Megan; Stuber, Kent; Report Jan 1, 2017 9325
Animal model of cognitive decline and neural transplantation of stem cells as a prospective therapy/Modelos animales de degeneracion cognitiva y uso de transplantes neurales de celulas madre como terapia/Modelos animais de declinio cognitivo e uso de transplantes neurais de celulas-mae como terapia. Bertuzzi, Leticia Domingues; Silva, Patricia Santos da; Neto, Elida Fluck Pereira; Nicolaidis, Rafae Jan 1, 2017 5287
Bladder and bowel dysfunction in children: An update on the diagnosis and treatment of a common, but underdiagnosed pediatric problem. Dos Santos, Joana; Lopes, Roberto I.; Koyle, Martin A. Report Jan 1, 2017 6477
Principia SGR invests EUR4m in AnaBios Corporation. Dec 28, 2016 136
Principia SGR invests EUR4m in AnaBios Corporation. Dec 28, 2016 132
Asceneuron names Michael Ryan chief medical officer. Dec 19, 2016 240
Asceneuron names Michael Ryan chief medical officer. Dec 19, 2016 236
Detection of meningococcal meningitis in cerebrospinal fluid of patients with neurological disorders in government hospitals of Karachi. Nov 30, 2016 2210
Eosinophilic granulomatosis with polyangiitis presenting with multiple intracerebral haemorrhages - A case report. Nov 30, 2016 1941
Chase Pharmaceuticals acquired by Allergan. Nov 24, 2016 178
Chase Pharmaceuticals acquired by Allergan. Nov 24, 2016 174
Neurotrope Issues Statement On Eli Lilly's Solanezumab. Nov 23, 2016 959
Clinical jobs in pipeline. Nov 21, 2016 304
Neurotrope Announces Private Placement of $20 Million. Nov 18, 2016 1333
United States : ACADIA Pharmaceuticals initiates Phase II Trial of Pimavanserin for Adjunctive Treatment in Patients with Negative Symptoms of Schizophrenia. Nov 18, 2016 201
Netherlands : Philips to unveil suite of advanced MR-based software applications for assessment of neurological disorders at RSNA 2016. Nov 18, 2016 609
INSPIRED: Targeting IRE1 in disease. Nov 17, 2016 413
Philips to unveil suite of advanced MR-based software applications for assessment of neurological disorders at RSNA 2016. Nov 17, 2016 1194
Skills for Autism by SKILLS Global Shortlisted for the Learning Technologies Awards 2016. Nov 15, 2016 947
Global Market Study on Electroencephalography (EEG) Devices: Increased Demand for Advanced Imaging Techniques for Brain Monitoring Has Led to Proliferation of EEG Devices in Recent Years, Persistence Market Research. Nov 15, 2016 1123
NASA Ames workers worry about toxins from Superfund site in California. Noack, Mark Nov 14, 2016 888
Aptinyx Awarded Up to $2.85 Million in NIH Grants to Research NMDA Receptor Modulation for the Treatment of Neuropathic Pain and Age-Related Cognitive Decline. Nov 10, 2016 746
Proteomics Market to Reach $25 Billion by 2024. Nov 8, 2016 839
MOON: Multi-modal Optical Diagnostics for Ocular and Neurodegenerative Disease. Nov 7, 2016 464
United States : ACADIA Pharmaceuticals initiates Phase III Trial of pimavanserin for adjunctive treatment in patients with schizophrenia. Nov 5, 2016 206
Three-dimensional Printed Patient-specific Drilling Templates for Expansive Open-door Laminoplasty. Rong, Xin; Wang, Bei-Yu; Deng, Yu-Xiao; Liu, Hao Case study Nov 5, 2016 1461
CResPace: Adaptive Bio-electronics for Chronic Cardiorespiratory Disease. Nov 4, 2016 418
QBRI in pioneering research in neurological disabilities. Nov 4, 2016 473
A Chain of Life for a Rare Neurodegenerative Disease. Nov 3, 2016 606
PDE Inhibitors Market, 2026: Approx 40 PDE Inhibitors Currently in Various Stages of Clinical/Preclinical Development - Research and Markets. Report Nov 3, 2016 2667
PDE Inhibitors Market, 2026: Approx 40 PDE Inhibitors Currently in Various Stages of Clinical/Preclinical Development - Research and Markets. Report Nov 3, 2016 2707
Amorsa Therapeutics names new director. Nov 2, 2016 231
Amorsa Therapeutics names new director. Nov 2, 2016 227
Injectable wires for fixing the brain: novel treatments for neurological diseases might be possible with a flexible mesh that can prod individual brain cells. Sklar, Julia Nov 1, 2016 477
Stem Cell Therapy Market Worth USD 60.94 Billion by 2022 - Scalar Market Research. Nov 1, 2016 865
Amorsa Therapeutics Appoints Anita Gupta, D.O., Pharm.D., to its Board of Directors. Nov 1, 2016 454
Stem Cell Therapy Market Worth USD 60.94 Billion by 2022 - Scalar Market Research. Nov 1, 2016 871
Neurodiagnostics Market Size Projected To Reach $18.3 Billion By 2024: Grand View Research, Inc. Nov 1, 2016 1018
Neurodiagnostics Market Size Projected To Reach $18.3 Billion By 2024: Grand View Research, Inc. Nov 1, 2016 1025
When blindness suddenly strikes: immediate veterinary attention may be able to save vision in this rare condition that affects senior cats. Nov 1, 2016 1257
The autoimmune response and neuropsychiatric disorders. Shimasaki, Craig Nov 1, 2016 1114
Fatal measles complication occurs more often than realized. Worcester, Sharon Nov 1, 2016 571
Dyke-Davidoff-Masson syndrome--typical imaging features/Dajk-davidov-masonov sindrom--tipicne radioloske karakteristike sindroma. Bjelan, Mladen; Kozic, Dusko; Njagulj, Vesna; Ragaji, Aleksandar; Koprivsek, Katarina; Lucic, Milos Report Nov 1, 2016 1623
BrainStorm Granted United States Patent for its Stem Cell Technology. Oct 31, 2016 737
QR Pharma Raises $800,000 of Series A Preferred Stock. Oct 27, 2016 470
Sri Lanka : Prof. Ranil De Silva delivered a talk on Brain Ageing at Panjab University. Oct 27, 2016 216
FAIR-PARK-II: Conservative iron chelation as a disease-modifying strategy in Parkinsons disease: a multicentric, parallel-group, placebo-controlled, randomized clinical trial of deferiprone. Clinical report Oct 26, 2016 485
Scientists developing MRI-gujded neural stem cell delivery method. Oct 24, 2016 473
United States : Toxic peptides disrupt membrane-less organelles in neurodegenerative disease. Oct 21, 2016 840
Zambon Announces Enrollment of First Patient in the Synapses Study (Drug Utilization Study N. Z7219N02). Clinical report Oct 18, 2016 1171
StockNewsNow.com Publishes New SNNLive Video Interview with ProMIS Neurosciences, Inc. Providing Company Overview, Milestones for 2016-2017. Oct 18, 2016 677
Neurorehabilitation Devices Market By Products, By Therapy Area and Segment Forecasts to 2024. Oct 18, 2016 582
Global Central Nervous System Disorders Pipeline Database 2016 - Research and Markets. Oct 17, 2016 417
ChemDiv, Torrey Pines Investment and DZNE Announce Research Collaboration. Oct 17, 2016 741
Global Central Nervous System Disorders Pipeline Database 2016 - Research and Markets. Oct 17, 2016 457
EuroPOND: Data-driven models for Progression Of Neurological Disease. Oct 17, 2016 473
BRAIN REPEATS: Repeat polymorphisms as genetic modifiers of brain function in healthy subjects and Huntington disease mutation carriers. Oct 17, 2016 382
MyeliNANO: Myelinic nanochannels in neurodegenerative diseases. Oct 14, 2016 374
United States : NIH nearly doubles investment in BRAIN Initiative research. Oct 14, 2016 874
Muscle Relaxants (botulinum Toxin) To Treat Neurological Diseases. Oct 14, 2016 134

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters